Le Guen S - Search Results

1

The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).

Lacour JP, Khemis A, Giordano-Labadie F, Martin L, Staumont-Salle D, Hacard F, Tian H, McBride D, Hollis K, Hunter S, Martin L, Lamirand A, Le Guen S, Balp MM, Berard F. Lacour JP, et al. Among authors: le guen s. Eur J Dermatol. 2018 Dec 1;28(6):795-802. doi: 10.1684/ejd.2018.3446. Eur J Dermatol. 2018. PMID: 30698148

2

[French adaptation of a new score for global assessment of psoriasis severity: The Simplified Psoriasis Index (SPI)].

Richard MA, Aractingi S, Joly P, Mahé E, Auquier P, Le Guen S, Acquadro C, Boucher F, Chalmers RJG. Richard MA, et al. Among authors: le guen s. Ann Dermatol Venereol. 2019 Dec;146(12):783-792. doi: 10.1016/j.annder.2019.08.004. Epub 2019 Oct 14. Ann Dermatol Venereol. 2019. PMID: 31623858 French.

3

Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports.

Hully M, Barnerias C, Chabalier D, Le Guen S, Germa V, Deladriere E, Vanhulle C, Cuisset JM, Chabrol B, Cances C, Vuillerot C, Espil C, Mayer M, Nougues MC, Sabouraud P, Lefranc J, Laugel V, Rivier F, Louvier UW, Durigneux J, Napuri S, Sarret C, Renouil M, Masurel A, Viallard ML, Desguerre I. Hully M, et al. Among authors: le guen s. Front Pediatr. 2020 Feb 18;8:4. doi: 10.3389/fped.2020.00004. eCollection 2020. Front Pediatr. 2020. PMID: 32133329 Free PMC article.

4

Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice.

Benturquia N, Le Guen S, Canestrelli C, Lagente V, Apiou G, Roques BP, Noble F. Benturquia N, et al. Among authors: le guen s. Neuroscience. 2007 Nov 9;149(3):477-86. doi: 10.1016/j.neuroscience.2007.08.003. Epub 2007 Aug 8. Neuroscience. 2007. PMID: 17905521 Free article.

5

Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.

Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F. Salzmann J, et al. Among authors: le guen s. Br J Pharmacol. 2003 Nov;140(5):831-8. doi: 10.1038/sj.bjp.0705506. Epub 2003 Sep 29. Br J Pharmacol. 2003. PMID: 14517176 Free PMC article.

6

Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.

Le Guen S, Mas Nieto M, Canestrelli C, Chen H, Fournié-Zaluski MC, Cupo A, Maldonado R, Roques BP, Noble F. Le Guen S, et al. Pain. 2003 Jul;104(1-2):139-48. doi: 10.1016/s0304-3959(02)00486-4. Pain. 2003. PMID: 12855323

7

Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.

Le Guen S, Gestreau C, Besson JM. Le Guen S, et al. Eur J Neurosci. 2003 Jun;17(11):2425-37. doi: 10.1046/j.1460-9568.2003.02678.x. Eur J Neurosci. 2003. PMID: 12814374

8

Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.

Buritova J, Le Guen S, Fournié-Zaluski MC, Roques BP, Besson JM. Buritova J, et al. Among authors: le guen s. Eur J Pain. 2003;7(3):241-9. doi: 10.1016/S1090-3801(02)00122-2. Eur J Pain. 2003. PMID: 12725847

9

Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.

Le Guen S, Catheline G, Fournié-Zaluski MC, Roques BP, Besson JM, Buritova J. Le Guen S, et al. Brain Res. 2003 Mar 28;967(1-2):106-12. doi: 10.1016/s0006-8993(02)04231-2. Brain Res. 2003. PMID: 12650971

10

RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.

Le Guen S, Noble F, Fournié-Zaluski MC, Roques BP, Besson JM, Buritova J. Le Guen S, et al. Eur J Pharmacol. 2002 Apr 26;441(3):141-50. doi: 10.1016/s0014-2999(01)01497-2. Eur J Pharmacol. 2002. PMID: 12063085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters